Showing results (71-80 of 261) with videos related to
Sort By:
Pageof 27
FEBS Letters|April 22, 2014
p53 and ribosome biogenesis stress: the essentialsLior Golomb, Sinisa Volarevic, Moshe OrenSeminars in Cell & Developmental Biology|November 17, 2009
Involvement of stromal p53 in tumor-stroma interactionsJair Bar, Neta Moskovits, Moshe OrenTrends in Genetics : TIG|April 27, 2010
Repression of transposable-elements - a microRNA anti-cancer defense mechanism?Reut Shalgi, Yitzhak Pilpel, Moshe OrenCancer Research|February 9, 2012
Consistency test of the cell cycle: roles for p53 and EGR1Yaara Zwang, Moshe Oren, Yosef YardenMolecular & Cellular Oncology|December 8, 2018
Functional characterization of the p53 "mutome"Eran Kotler, Eran Segal, Moshe OrenThe Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|July 27, 2014
Endothelial matrix assembly during capillary morphogenesis: insights from chimeric TagRFP-fibronectin matrixFumin Chang, Christopher A Lemmon, Voraphoj Nilaratanakul, et al.Journal of Molecular Medicine (Berlin, Germany)|November 19, 2014
p53 in liver pathologies-taking the good with the badMeital Charni, Noa Rivlin, Alina Molchadsky, et al.Carcinogenesis|June 20, 2014
Caught in the cross fire: p53 in inflammationTomer Cooks, Curtis C Harris, Moshe OrenOncogene|April 6, 2004
Downregulation of beta-catenin by p53 involves changes in the rate of beta-catenin phosphorylation and Axin dynamicsElina Levina, Moshe Oren, Avri Ben-Ze'evCancer Research|December 26, 2003
Expression of prolyl-hydroxylase-1 (PHD1/EGLN2) suppresses hypoxia inducible factor-1alpha activation and inhibits tumor growthNeta Erez, Michael Milyavsky, Raya Eilam, et al.Pageof 27